368 related articles for article (PubMed ID: 22389029)
1. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.
Liu X; Cheng Y; Sheng W; Lu H; Xu Y; Long Z; Zhu H; Wang Y
J Surg Oncol; 2010 Sep; 102(3):249-55. PubMed ID: 20740583
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach.
Liu X; Cheng Y; Sheng W; Lu H; Xu X; Xu Y; Long Z; Zhu H; Wang Y
Am J Surg Pathol; 2010 Oct; 34(10):1465-71. PubMed ID: 20871221
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
Gao YB; Zhang DF; Jin XL; Xiao JC
J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
[TBL] [Abstract][Full Text] [Related]
5. High level of serum AFP is an independent negative prognostic factor in gastric cancer.
Chen Y; Qu H; Jian M; Sun G; He Q
Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668
[TBL] [Abstract][Full Text] [Related]
6. Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Iso Y; Sawada T; Shimoda M; Rokkaku K; Ohkura Y; Kubota K
Hepatogastroenterology; 2005; 52(66):1930-2. PubMed ID: 16334809
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Kono K; Amemiya H; Sekikawa T; Iizuka H; Takahashi A; Fujii H; Matsumoto Y
Dig Surg; 2002; 19(5):359-65; discussion 365. PubMed ID: 12435906
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological characteristics and prognosis of alpha-fetoprotein producing gastric cancer].
Lew DH; Jung WT; Kim HJ; Min HJ; Ha CY; Kim HJ; Kim TH; Ko GH
Korean J Gastroenterol; 2013 Dec; 62(6):327-35. PubMed ID: 24365731
[TBL] [Abstract][Full Text] [Related]
9. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.
Kamei S; Kono K; Amemiya H; Takahashi A; Sugai H; Ichihara F; Fujii H; Matsumoto Y
J Gastroenterol; 2003; 38(6):540-7. PubMed ID: 12825129
[TBL] [Abstract][Full Text] [Related]
11. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.
Nagai E; Ueyama T; Yao T; Tsuneyoshi M
Cancer; 1993 Sep; 72(6):1827-35. PubMed ID: 7689918
[TBL] [Abstract][Full Text] [Related]
12. [A case of hepatoid adenocarcinoma of the stomach].
Li XZ
Zhonghua Zhong Liu Za Zhi; 1989 Jan; 11(1):74-5. PubMed ID: 2476287
[TBL] [Abstract][Full Text] [Related]
13. The potential for the development of liver metastasis from alpha-fetoprotein-producing human gastric carcinomas in nude mice.
Sawada H; Nakatani K; Watanabe A; Nishiwada T; Okumura T; Yamada Y; Yano T; Shino Y; Yamada T; Tanase M
Jpn J Clin Oncol; 1992 Oct; 22(5):303-7. PubMed ID: 1281894
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
15. Roles of histological findings and serum AFP levels in the prognosis of AFP-producing gastric cancers.
Uefuji K; Ichikura T; Tamakuma S
Jpn J Clin Oncol; 1994 Jun; 24(3):135-40. PubMed ID: 7516444
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach].
Yang CK; Zhao WJ; Dai QB; Zhang HH; Zheng W
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):245-8. PubMed ID: 17520383
[TBL] [Abstract][Full Text] [Related]
18. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.
Chang YC; Nagasue N; Abe S; Taniura H; Kumar DD; Nakamura T
Am J Gastroenterol; 1992 Mar; 87(3):321-5. PubMed ID: 1371637
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach.
Zhang JF; Shi SS; Shao YF; Zhang HZ
Chin Med J (Engl); 2011 May; 124(10):1470-6. PubMed ID: 21740800
[TBL] [Abstract][Full Text] [Related]
20. [AFP-producing gastric cancer and hepatoid gastric cancer].
Wang YK; Zhang XT
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]